CDH2 and atherosclerosis: By quantifying the expression of Rac and Rho in the VSMC spheroids, the authors found that FAK-Rac-N-cadherin or FAK-Rho-N-cadherin are necessary for VSMC spheroid formation, which might be considered a future target for treating atherosclerosis-related neointima formation (153).